Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3464 of 6351
-
Can a booklet boost knee surgery recovery?
Symptom relief CompletedThe benefit of preoperative rehabilitation treatment combining physiotherapy and targeted education for patient undergoing Total Knee replacement (TKR) is now well known. Thus, there is lack of validated booklet containing evidence based informations. Our aim is to assess the im…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Gum treatment may ease arthritis symptoms, study finds
Disease control CompletedAlthough RA pathomechanisms remains incompletely understood, periodontitis and RA share pathogenic features : genetic and environmental influences, chronic inflammatory disease, immunoregulatory imbalance, bacterial factors, persistence of antigen/peptide and clinical factors (co…
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Massive cancer biobank aims to fuel precision medicine breakthroughs
Knowledge-focused Recruiting nowThe Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of pr…
Sponsor: Caris Science, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can new scans predict myeloma before it strikes?
Knowledge-focused CompletedBackground: \- Recent studies have shown that the premalignant conditions monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) have a high risk of progressing to multiple myeloma (MM). There are currently no known effective treatments t…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Experimental drug pomalidomide tested in rare blood cancer
Disease control Stopped earlyThis phase I trial studies the side effects and best dose of pomalidomide in treating patients with Waldenstrom macroglobulinemia that has returned after a period of improvement (relapsed) or does not respond to treatment (refractory). Pomalidomide may stimulate the immune system…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Can a common phosphate binder tame kidney disease hormones?
Disease control CompletedThe purpose of this study is to evaluate in Chronic Kidney Disease (CKD) patients not on dialysis and who have an Fibroblast growth factor 23 (FGF23) serum levels elevated, the effect of non calcic phosphate binder: sevelamer carbonate. This treatment could lead to a diminution o…
Phase 3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC
-
Zapping kidney cancer: new radiation study aims to avoid surgery
Disease control CompletedStereotactic radiotherapy is a technique that allows the delivery of a high dose of radiation over few fractions (3-6) with great precision. It thus allows "tumor ablation" and optimal preservation of healthy tissues. Initially developed in small-sized (\<5 cm) lung cancers this …
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
Can a simple inhalation tame lung inflammation in older women?
Disease control CompletedTo investigate the physical inflammation inhibition effects of EIL (Ectoin-Hydro-Complex) in subjects of the established SALIA-cohort and the preventive effects on lung function decline.
Sponsor: Bitop AG • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Oxygen mapping in pancreatic tumors could reveal hidden clues to aggressive cancer
Knowledge-focused CompletedThis study involves the administration of a hypoxia marker, pimonidazole hydrochloride, taken orally approximately 24 hours before surgical resection of a pancreatic tumor in order to identify areas of lower oxygen content on tumor samples.
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Gift cards for good health: can rewards help native women kick the habit and shed pounds?
Disease control CompletedA randomized controlled trial for the efficacy of contingency management to encourage smoking cessation and weight loss.
Sponsor: Washington State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Iraq war Veterans' mental health tracked for years in new study
Knowledge-focused OngoingThis is a research study examining health effects of the Iraq War, especially those effects involving mental health. This study is a follow-up to the Neurocognition Deployment Health Study (NDHS), also called "Prospective Assessment of Neurocognition in Future Gulf-deployed and G…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Scientists hunt for thyroid cancer genes in families
Knowledge-focused Recruiting nowBackground: \- Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of thyroid cancer, but little is known about possible genes that may cause the cancer. More research is need…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Is surgery better than watching for seniors with high calcium?
Disease control CompletedGeneral consensus and contemporary guidelines, recommend surgery for primary hyperparathyroidism (pHPT)for all patients below the age of 50, for patients with pronounced hypercalcemia and for patients with organ complications to the disease (osteoporosis and decreased renal funct…
Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New cocktail targets rare tumor in kids
Disease control OngoingThis study adds irinotecan, temozolomide and bevacizumab to the chemotherapy regimen currently used to treat Desmoplastic small round cell tumor (DSRCT). The investigators are doing this study to find out what effects, good and/or bad, the combination of irinotecan, temozolomide …
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 06:00 UTC
-
Could vitamin d ease sarcoidosis? new trial investigates
Disease control Recruiting nowThis study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Team approach aims to boost cancer pill adherence and safety
Disease control CompletedThe purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of …
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a common arthritis drug ease hand pain? new trial tests methotrexate
Disease control CompletedInterest of methotrexate in inflammatory rheumatisms was demonstrated since several years. At present time,there is no effective treatment against digital arthritis. The investigators purpose to measure the efficacy of methotrexate on digital arthritis. In this aim, two groups …
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
HIV patients with liver failure get new drug combo tested in transplant study
Disease control CompletedThis phase I/II, multi-center study is designed to determine the pharmacokinetic profile of Raltegravir in patients with end stage liver disease and to assess drug-drug interaction when Raltegravir is combined with immunosuppressive therapy in liver transplant recipients.
Phase 1/2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Stem cells shot into penis aim to restore erections after prostate surgery
Disease control CompletedErectile dysfunction is a frequent adverse event after radical prostatectomy for prostate cancer. It is the consequence of penile vascular damage, mainly arterial insufficiency and venous leakage associated with fibrosis of the corpus cavernous. Apoptosis of penile cells, includ…
Phase 1/2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Scientists hunt for hidden genes behind nerve disease severity
Knowledge-focused Recruiting nowThis project includes two projects. One is looking for new genes that cause Charcot Marie Tooth disease (CMT). The other is looking for genes that do not cause CMT, but may modify the symptoms a person has.
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC